ClinConnect ClinConnect Logo
Search / Trial NCT01929434

Efficacy of Stem Cell Transplantation Compared to Rehabilitation Treatment of Patients With Cerebral Paralysis

Launched by GENERAL HOSPITAL OF CHINESE ARMED POLICE FORCES · Aug 21, 2013

Trial Information

Current as of May 16, 2025

Completed

Keywords

Cerebral Palsy Cell Transplantation Rehabilitation

ClinConnect Summary

Patients enrolled in this study need to finish our whole follow-up survey for 12 months, which is carried out by clinical doctors, rehabilitators and epidemiologist.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients with diagnosis of cerebral palsy.
  • Patients' curator must be able to give voluntary consent.
  • Exclusion Criteria:
  • Intracranial infection.
  • Severe respiratory and circulatory system diseases.
  • Hematologic malignancies.
  • Positive serological tests such as AIDS, hepatitis B virus, hepatitis C virus and syphilis (antigen or antibody).
  • Tumors.
  • Genetic and metabolic diseases.

About General Hospital Of Chinese Armed Police Forces

The General Hospital of Chinese Armed Police Forces is a prestigious medical institution dedicated to advancing healthcare through innovative research and clinical trials. As a leading sponsor of clinical studies, the hospital integrates military and civilian healthcare expertise to enhance medical practices and patient outcomes. Committed to upholding the highest ethical standards and regulatory compliance, the hospital fosters a collaborative environment that encourages scientific inquiry and the development of novel therapeutic interventions. Its multidisciplinary approach ensures comprehensive patient care while contributing to the global body of medical knowledge.

Locations

Beijing, Beijing, China

Patients applied

0 patients applied

Trial Officials

Yihua An, Doctor

Study Director

the General Hospital of Chinese People's Armed Police Forces

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials